Masthead
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 28, 2016 Category: Pathology Source Type: research
Editorial Board
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 28, 2016 Category: Pathology Source Type: research
Table of Contents
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 28, 2016 Category: Pathology Source Type: research
Topics
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 28, 2016 Category: Pathology Source Type: research
COVER (PMS 180&K) (p/u from previous issue w/updates)
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 21, 2016 Category: Pathology Source Type: research
MASTHEAD (p/u from previous issue)
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 21, 2016 Category: Pathology Source Type: research
EDITORIAL BOARD (p/u from previous issue)
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 21, 2016 Category: Pathology Source Type: research
TABLE OF CONTENTS (p/u from previous issue w/updates)
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 21, 2016 Category: Pathology Source Type: research
TOPICS (p/u from previous issue)
(Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 21, 2016 Category: Pathology Source Type: research
Blue nevus and “malignant blue nevus:” A concise review
Blue nevi are a heterogeneous group of lesions that can display a variety of different clinicopathological characteristics. Although attempts are made to classify each lesion into defined subtypes, there can be overlap between the subtypes. The clinical and histolopathologic features of common blue nevi and cellular blue nevi are discussed, as well as blue nevi with atypical features and malignant lesions with features of blue nevi. (Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 18, 2016 Category: Pathology Authors: Jessica Zarah Sugianto, Jonathan Scott Ralston, John S. Metcalf, Courtney L. McFaddin, M. Timothy Smith Source Type: research
Blue Nevus & “Malignant Blue Nevus:” A Concise Review
Blue nevi are a heterogeneous group of lesions that can display a variety of different clinicopathological characteristics. Although attempts are made to classify each lesion into defined subtypes, there can be overlap between the subtypes. The clinical and histolopathologic features of common blue nevi and cellular blue nevi are discussed, as well as blue nevi with atypical features and malignant lesions with features of blue nevi. (Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 18, 2016 Category: Pathology Authors: Jessica Zarah Sugianto, Jonathan Scott Ralston, John S. Metcalf, Courtney L. McFaddin, M. Timothy Smith Source Type: research
Introduction
According to the website of the American Cancer Society, an estimated 76,100 new cases of cutaneous melanoma will be recognized in 2014, and about 9700 annual deaths are expected from that tumor type. Yearly incidence rates for melanoma have risen steadily over the past 30 years, but the reasons for that observation are not fully understood. Malignant melanoma and histologically similar pigmented skin lesions are common diagnostic challenges, and pathologic interpretations thereof are often disputed among experts. (Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 14, 2016 Category: Pathology Authors: M. Timothy Smith, Mark R. Wick Source Type: research
Selected benign cutaneous lesions that may simulate melanoma histologically
This article considers those entities, including melanocytic hyperplasia, cellular nodules in congenital nevi, atypical lentiginous melanocytic proliferations, “special site” nevi, epithelioid histiocytoma, neurothekeoma, cellular schwannoma, and proliferating scars. (Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 14, 2016 Category: Pathology Authors: Mark R. Wick Source Type: research
Mucosal melanomas: Site-specific information, comparisons with cutaneous tumors, and differential diagnosis
Melanoma of the skin is the fifth leading new cancer diagnosis, having accounted for almost 77,000 cases and more than 9000 deaths in the United States in 2013. Although cutaneous neoplasms of this type are relatively common, their mucosal counterparts are not. Mucosal melanomas comprise approximately 1.3% of all melanocytic malignancies. Although they are rare, these lesions present at an advanced stage with more adverse prognoses. In addition, at a molecular level, they have proven to be distinct entities because they possess genetic mutations not usually seen in their cutaneous counterparts. (Source: Seminars in Diagnostic Pathology)
Source: Seminars in Diagnostic Pathology - April 14, 2016 Category: Pathology Authors: Nicole R. Dominiak, Mark R. Wick, M. Timothy Smith Source Type: research
